Abstract
The influence of mepiprazole (EMD 16,923), a new pyrazol-ylalkyl-piperazine derivative, on the uptake of 3H-norepinephrine (NE), 3H-dopamine (DA), and 3H-serotonin (5-HT) into rat brain synaptosomes from cerebral cortex, corpus striatum, and hypothalamus was investigated in comparison with several psychotropic drugs, including oxypertine, d-amphetamine, imipramine, desipramine, chlorimipramine, amitriptyline, and chlorpromazine in vitro. Mepiprazole was a relatively weak inhibitor of monoamine uptake and exhibited its strongest action on the hypothalamic 5-HT uptake, being almost equipotent with desipramine (IC50=0.9 μM). Furthermore, the influence of the drugs on the retention of 3H-amines previously taken up by whole rat brain synaptosomes was studied. Unlike the tricyclic antidepressants, mepiprazole as well as oxypertine and d-amphetamine markedly increased the efflux of radioactivity during a 20-min incubation at 37°C at low concentrations (10−6 to 10−5 M), whereas at 10−4M all drugs greatly enhanced the efflux. The ability of mepiprazole to increase 5-HT concentration at the receptor level by a combination of neuronal uptake inhibition and release is discussed in relationship to the central actions of the drug.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Azzaro, A. J., Ziance, R. J., Rutledge, C. O.: The importance of neuronal uptake of amines for amphetamine-induced release of 3H-norepinephrine from isolated brain tissue. J. Pharmacol. exp. Ther. 189, 110–118 (1974)
Carlsson, A., Corrodi, H., Fuxe, K., Hökfelt, T.: Effect of anti-depressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-α-ethyl-metatyramine. Europ. J. Pharmacol. 5, 357–366 (1969)
Carlsson, A., Fuxe, K., Hamberger, B., Lindquist, M.: Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catechol-amine neurons. Acta physiol. scand. 67, 481–497 (1966)
Cheng, Y., Prusoff, W. H.: Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099–3108 (1973)
Corrodi, H., Fuxe, K.: The effect of imipramine on central monoamine neurons. J. Pharm. Pharmacol. 20, 230–231 (1968)
Cuasnicú, A.: Comparación doble-ciego del nuevo tranquilizante Mepiprazol con diazepan. Therapia (Revista Mensual de Terapeutica) 49, 34–40 (1974)
Dotevall, G., Groll, E.: Controlled clinical trial of mepiprazole in irritable bowel syndrome. Brit. med. J. 1974 IV, 16–18
Foguet, G.: Evaluación terapéutica de un nuevo tranquilizante menor. El Dia Medico 46, 698–704 (1974)
Glowinski, J., Axelrod, J., Iversen, L. L.: Regional studies of catecholamines in the rat brain. IV. Effects of drugs on the disposition and metabolism of 3H-norepinephrine and 3H-dopamine. J. Pharmacol. exp. Ther. 153, 30–41 (1966)
Glowinski, J., Iversen L. L.: Regional studies of catecholamines in the rat brain. I. The disposition of 3H-norepinephrine, 3H-dopamine and 3H-dopa in various regions of the brain. J. Neurochem. 13, 655–669 (1966)
Goncalves, N.: Das klinische Wirkungsbild des Tranquilizers Mepiprazol bei hospitalisierten Schizophrenen. Psychopharmacologia (Berl.) 25, 281–290 (1972)
Goncalves, N., Fieguth, G.: Veränderung der Aufmerksamkeits-und Konzentrationsleistung chronisch Schizophrener unter zusätzlicher Behandlung mit Mepiprazol und ihre Bedeutung für die Resozialisierung. Pharmakopsychiat. 6, 167–177 (1973)
Harris, J. E., Baldessarini, R. J.: Uptake of 3H-catecholamines by homogenates of rat corpus striatum and cerebral cortex: Effects of amphetamine analogues. Neuropharmacology 12, 669–679 (1973)
Hassler, R., Bak, I. J., Kim, J. S.: Unterschiedliche Entleerung der Speicherorte für Noradrenalin, Dopamin und Serotonin als Wirkungsprinzip des Oxypertins. Nervenarzt 41, 105–118 (1970)
Heikkila, R. E., Orlansky, H., Cohen, G.: Studies on the distinction between uptake inhibition and release of 3H-dopamine in rat brain tissue slices. Biochem. Pharmacol. 24, 847–852 (1975)
Hamberger, B.: Reserpine-resistant uptake of catecholamines in isolated tissues of the rat. Acta physiol scand. 71, Suppl. 295, 1–56 (1967)
Henkel, D., Bastine, R.: Vergleichende Untersuchungen zur systematischen Desensibilisierung in Gruppen mit verbal-muskulärer und pharmakologischer Entspannungsinduktion. Z. klin. Psychol. 1, 150–163 (1972)
Horn, A. S., Coyle, J. D., Snyder, S. H.: Catecholamine uptake by synaptosomes from rat brain. Structure-activity relationships of drugs with differential effects on dopamine and norepinephrine neurons. Molec. Pharmacol. 7, 66–80 (1971)
Kebabian, J. W., Petzold, G. L., Greengard, P.: Dopamine sensitive adenylate cyclase in the caudate nucleus of the rat brain and its similarity to the “dopamine receptor”. Proc. nat. Acad. Sci. (Wash.) 69, 2145–2149 (1972)
Leitz, F. H., Stefano, F. J. E.: Desipramine-induced release of norepinephrine from heart. Biochem. Pharmacol. 19, 1797–1801 (1970)
Lineweaver, H., Burk, D.: The determination of enzyme dissociation constants. J. Amer. chem. Soc. 56, 658–666 (1934)
Lowry, O., Rosebrough, N., Farr, A., Randall, R.: Protein measurements with the Folin phenol reagent. J. biol. Chem. 193, 265–275 (1951)
Müller-Calgan, H.: Psychopharmacological characteristics of certain new tranquilizing piperazine derivatives in rats and rhesus monkeys. In: Proceedings of 5th World Congress on Psychiatry, Mexico City (1971)
Müller-Calgan, H.: A pharmacological model with rhesus monkeys for the prediction of selective depression of psychic functions. Activ. nerv. sup. (Praha) 16, 1–3 (1974)
Ng, K. Y., Chase, T. N., Kopin, I. J.: Drug-induced release of 3H-norepinephrine and 3H-serotonin from brain slices. Nature (Lond.) 228, 468–469 (1970)
Placheta, P., Singer, E., Kriwanek, W., Hertting, G.: The effect of mepiprazole on the uptake of norepinephrine, dopamine, and serotonin into rat brain synaptosomes. Naunyn-Schmiede-berg's Arch Pharmacol., Suppl. 287, R4 (1975)
Pöldinger, W.: Clinical trial of 3-methyl-5-(β-N′-[N-m-chlorophenylpiperazino]ethyl)-pyrazole dihydrochloride (mepiprazole) in the therapy of psychovegetative disorders. Int. Pharmacopsychiat. 10, 1–8 (1975)
Ross, S. B., Renyi, A. L.: Inhibition of the uptake of tritiated catecholamines by antidepressant and related agents. Europ. J. Pharmacol. 2, 181–186 (1967)
Ross, S. B., Renyi, A. L.: Tricyclic antidepressant agents. I. Comparison of the inhibition of the uptake of 3H-noradrenaline and 14C-5-hydroxytryptamine in slices and crude synaptosome preparations of the midbrain-hypothalamus region of the rat brain. Acta pharmacol. (Kbh.) 36, 382–394 (1975)
Shaskan, E. G., Snyder, S. H.: Kinetics of serotonin accumulation into slices from rat brain: Relationship to catecholamine uptake. J. Pharmacol. exp. Ther. 175, 404–418 (1970)
Snyder, S. H., Coyle, J. T.: Regional differences in 3H-norepinephrine and 3H-dopamine uptake into rat brain homogenates. J. Pharmacol. exp. Ther. 165, 78–86 (1969)
Van Rossum, J. M.: The significance of dopamine-receptor block-ade for the mechanism of action of neuroleptic drugs. Arch. int. Pharmacodyn. 160, 492–494 (1966)
Whittaker, V. P.: The synaptosome. In: Handbook of neurochemistry, Vol. 2, A. A. Lajtha, ed., pp. 327–364. New York: Plenum Press 1969
Wong, D. T., Horng, J., Fuller, R. W.: Kinetics of serotonin accumulation into synaptosomes of rat brain-Effects of amphetamine and chloroamphetamines. Biochem. Pharmacol. 22, 311–322 (1973)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Placheta, P., Singer, E., Kriwanek, W. et al. Mepiprazole, a new psychotropic drug: Effects on uptake and retention of monoamines in rat brain synaptosomes. Psychopharmacology 48, 295–301 (1976). https://doi.org/10.1007/BF00496865
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00496865